Texas General Counsel Forum (TGCF) Virtual CLE Program | CRISPR Technology


Associate Matthew Knabel, Ph.D., will present “CRISPR Technology” to the Texas General Counsel Forum (TGCF) on October 6.

Fish is a proud supporter of the TGCF, which is committed to serving in-house leadership in Texas. With more than 650 general and senior managing counsel members representing over 450 companies across the state, the Forum has established a network unparalleled in the legal community. Through the strategic programming and networking events hosted in their chapter cities, TGCF’s goal is to build relationships, exchange best-practices, and spearhead thought leadership amongst members and across the legal community. Panel details are below.

CRISPR Technology
Thursday, October 6, 2022 | 12:00-1:00 p.m. CT

Widely referred to as a game-changing genetic engineering technique, CRISPR is the most precise gene editing method, allowing scientists to detect and rewrite genetic code. It has the potential to revolutionize the healthcare industry, where it is showing early promise in the treatment of cancer, sickle cell anemia, and other disorders. But powerful new technologies like CRISPR invariably pose risks for patients and raise novel legal questions that eventually must be answered.

Please join Fish attorney Matt Knabel, Ph.D., for his presentation on CRISPR technology, in which he will discuss:

  • What is CRISPR and how does it work?
  • In what settings is CRISPR used?
  • What CRISPR therapeutics are being developed presently?
  • What legal issues does CRISPR raise?
  • What’s next for CRISPR in the coming decade?


To learn more, click here.